Literature DB >> 21422808

Differential recognition of viral RNA by RIG-I.

Alina Baum1, Adolfo García-Sastre.   

Abstract

Retinoic acid inducible gene I (RIG-I) is a pattern recognition receptor (PRR) responsible for detection of nucleic acids from pathogens in the cytoplasm of infected cells and induction of type I interferon (IFN). RIG-I -specific pathogen associated molecular patterns (PAMPs) are characterized by RNA molecules with a 5'-triphosphate (5'-ppp) group and partial double-stranded composition. Although many RNA molecules capable of activating RIG-I have been described, the exact nature of viral RNAs which are responsible for triggering RIG-I activity during the course of an infection has not been extensively explored and the specificity of RIG-I for various viral RNA molecules remains largely unknown. By examining endogenous RIG-I/RNA complexes in influenza virus and Sendai virus infected cells we were able to identify viral RNA molecules which specifically associated with RIG-I during infection. We showed that in Sendai virus infected cells, RIG-I specifically and preferentially associated with the copy-back defective interfering (DI) particle RNA and not with the full-length Sendai virus genome or Sendai virus encoded mRNAs. In influenza virus infected cells RIG-I also preferentially associated with DI RNAs as well as with the shorter genomic segments.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21422808      PMCID: PMC3100765          DOI: 10.4161/viru.2.2.15481

Source DB:  PubMed          Journal:  Virulence        ISSN: 2150-5594            Impact factor:   5.882


  26 in total

1.  Sendai virus defective-interfering genomes and the activation of interferon-beta.

Authors:  Laura Strahle; Dominique Garcin; Daniel Kolakofsky
Journal:  Virology       Date:  2006-05-02       Impact factor: 3.616

2.  A structural basis for discriminating between self and nonself double-stranded RNAs in mammalian cells.

Authors:  Joao Trindade Marques; Thalie Devosse; Die Wang; Maryam Zamanian-Daryoush; Paul Serbinowski; Rune Hartmann; Takashi Fujita; Mark A Behlke; Bryan R G Williams
Journal:  Nat Biotechnol       Date:  2006-04-30       Impact factor: 54.908

3.  5'-Triphosphate RNA is the ligand for RIG-I.

Authors:  Veit Hornung; Jana Ellegast; Sarah Kim; Krzysztof Brzózka; Andreas Jung; Hiroki Kato; Hendrik Poeck; Shizuo Akira; Karl-Klaus Conzelmann; Martin Schlee; Stefan Endres; Gunther Hartmann
Journal:  Science       Date:  2006-10-12       Impact factor: 47.728

4.  Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses.

Authors:  Hiroki Kato; Osamu Takeuchi; Shintaro Sato; Mitsutoshi Yoneyama; Masahiro Yamamoto; Kosuke Matsui; Satoshi Uematsu; Andreas Jung; Taro Kawai; Ken J Ishii; Osamu Yamaguchi; Kinya Otsu; Tohru Tsujimura; Chang-Sung Koh; Caetano Reis e Sousa; Yoshiharu Matsuura; Takashi Fujita; Shizuo Akira
Journal:  Nature       Date:  2006-04-09       Impact factor: 49.962

5.  Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling.

Authors:  Eileen Foy; Kui Li; Rhea Sumpter; Yueh-Ming Loo; Cynthia L Johnson; Chunfu Wang; Penny Mar Fish; Mitsutoshi Yoneyama; Takashi Fujita; Stanley M Lemon; Michael Gale
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-14       Impact factor: 11.205

6.  IFNbeta induction by influenza A virus is mediated by RIG-I which is regulated by the viral NS1 protein.

Authors:  Bastian Opitz; Amira Rejaibi; Bianca Dauber; Jamina Eckhard; Maya Vinzing; Bernd Schmeck; Stefan Hippenstiel; Norbert Suttorp; Thorsten Wolff
Journal:  Cell Microbiol       Date:  2006-11-28       Impact factor: 3.715

7.  RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates.

Authors:  Andreas Pichlmair; Oliver Schulz; Choon Ping Tan; Tanja I Näslund; Peter Liljeström; Friedemann Weber; Caetano Reis e Sousa
Journal:  Science       Date:  2006-10-12       Impact factor: 47.728

8.  A novel broad-spectrum treatment for respiratory virus infections: influenza-based defective interfering virus provides protection against pneumovirus infection in vivo.

Authors:  Andrew J Easton; Paul D Scott; Nicole L Edworthy; Bo Meng; Anthony C Marriott; Nigel J Dimmock
Journal:  Vaccine       Date:  2011-02-12       Impact factor: 3.641

9.  Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems.

Authors:  A García-Sastre; A Egorov; D Matassov; S Brandt; D E Levy; J E Durbin; P Palese; T Muster
Journal:  Virology       Date:  1998-12-20       Impact factor: 3.616

10.  The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses.

Authors:  Mitsutoshi Yoneyama; Mika Kikuchi; Takashi Natsukawa; Noriaki Shinobu; Tadaatsu Imaizumi; Makoto Miyagishi; Kazunari Taira; Shizuo Akira; Takashi Fujita
Journal:  Nat Immunol       Date:  2004-06-20       Impact factor: 25.606

View more
  37 in total

1.  ATPase-driven oligomerization of RIG-I on RNA allows optimal activation of type-I interferon.

Authors:  Jenish R Patel; Ankur Jain; Yi-ying Chou; Alina Baum; Taekjip Ha; Adolfo García-Sastre
Journal:  EMBO Rep       Date:  2013-07-12       Impact factor: 8.807

2.  Foot-and-mouth disease virus structural protein VP3 degrades Janus kinase 1 to inhibit IFN-γ signal transduction pathways.

Authors:  Dan Li; Jin Wei; Fan Yang; Hua-Nan Liu; Zi-Xiang Zhu; Wei-Jun Cao; Shu Li; Xiang-Tao Liu; Hai-Xue Zheng; Hong-Bing Shu
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

3.  Influenza A Virus Panhandle Structure Is Directly Involved in RIG-I Activation and Interferon Induction.

Authors:  GuanQun Liu; Hong-Su Park; Hyun-Mi Pyo; Qiang Liu; Yan Zhou
Journal:  J Virol       Date:  2015-03-25       Impact factor: 5.103

4.  The influenza NS1 protein modulates RIG-I activation via a strain-specific direct interaction with the second CARD of RIG-I.

Authors:  Alexander S Jureka; Alex B Kleinpeter; Jennifer L Tipper; Kevin S Harrod; Chad M Petit
Journal:  J Biol Chem       Date:  2019-12-16       Impact factor: 5.157

5.  RIG-I and TLR4 responses and adverse outcomes in pediatric influenza-related critical illness.

Authors:  Tanya Novak; Mark W Hall; Douglas R McDonald; Margaret M Newhams; Anushay J Mistry; Angela Panoskaltsis-Mortari; Peter M Mourani; Laura L Loftis; Scott L Weiss; Keiko M Tarquinio; Barry Markovitz; Mary E Hartman; Adam Schwarz; Wolfgang G Junger; Adrienne G Randolph
Journal:  J Allergy Clin Immunol       Date:  2020-02-06       Impact factor: 10.793

6.  A Single Amino Acid Substitution within the Paramyxovirus Sendai Virus Nucleoprotein Is a Critical Determinant for Production of Interferon-Beta-Inducing Copyback-Type Defective Interfering Genomes.

Authors:  Asuka Yoshida; Ryoko Kawabata; Tomoyuki Honda; Kouji Sakai; Yasushi Ami; Takemasa Sakaguchi; Takashi Irie
Journal:  J Virol       Date:  2018-02-12       Impact factor: 5.103

7.  Paramyxovirus V Proteins Interact with the RIG-I/TRIM25 Regulatory Complex and Inhibit RIG-I Signaling.

Authors:  Maria T Sánchez-Aparicio; Leighland J Feinman; Adolfo García-Sastre; Megan L Shaw
Journal:  J Virol       Date:  2018-02-26       Impact factor: 5.103

8.  Incoming RNA virus nucleocapsids containing a 5'-triphosphorylated genome activate RIG-I and antiviral signaling.

Authors:  Michaela Weber; Ali Gawanbacht; Matthias Habjan; Andreas Rang; Christoph Borner; Anna Mareike Schmidt; Sophie Veitinger; Ralf Jacob; Stéphanie Devignot; Georg Kochs; Adolfo García-Sastre; Friedemann Weber
Journal:  Cell Host Microbe       Date:  2013-03-13       Impact factor: 21.023

9.  Sequence analysis of in vivo defective interfering-like RNA of influenza A H1N1 pandemic virus.

Authors:  Kazima Saira; Xudong Lin; Jay V DePasse; Rebecca Halpin; Alan Twaddle; Timothy Stockwell; Brian Angus; Alessandro Cozzi-Lepri; Marina Delfino; Vivien Dugan; Dominic E Dwyer; Matthew Freiberg; Andrzej Horban; Marcelo Losso; Ruth Lynfield; Deborah N Wentworth; Edward C Holmes; Richard Davey; David E Wentworth; Elodie Ghedin
Journal:  J Virol       Date:  2013-05-15       Impact factor: 5.103

10.  Defective RNA sensing by RIG-I in severe influenza virus infection.

Authors:  S E Jørgensen; M Christiansen; L B Ryø; H H Gad; J Gjedsted; P Staeheli; J G Mikkelsen; M Storgaard; R Hartmann; T H Mogensen
Journal:  Clin Exp Immunol       Date:  2018-03-24       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.